Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT in Children With Ulcerative Colitis
NCT02291523Phase 1Unknown
- Sponsor
- Children's Hospital Los Angeles
- Start
- Nov 2016
- Primary completion
- Nov 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of fecal microbiome transplant in ulcerative colitis (UC) (2 arms), sponsored by Children's Hospital Los Angeles. Primary endpoint: Disease remission based on Pediatric Ulcerative Colitis Activity Index (PUCAI) scores (<10) at 12 months. Status: unknown.
02
Drugs
fecal microbiome transplant
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02291523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291523.